Month: April 2024

2065 posts
MUSINSA Achieving "Record High" with Nearly US$ 733 million in Sales, Up 40% Last Year, Continues to Generate Solid Revenue Both Online and Offline

MUSINSA Achieving "Record High" with Nearly US$ 733 million in Sales, Up 40% Last Year, Continues to Generate Solid Revenue Both Online and Offline

With a consolidated sales figure of US$ 732.9 million, an increase of…
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine

YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine

GAITHERSBURG, Md., April 9, 2024 /PRNewswire/ — YS Biopharma Co., Ltd. (Nasdaq:…
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting

Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting

BEIJING, SHANGHAI, and SAN DIEGO, April 9, 2024 /PRNewswire/ — Jacobin Pharma…
EXHIBITORS AND BUYERS UPBEAT AT MALAYSIAN INTERNATIONAL FURNITURE FAIR 2024

EXHIBITORS AND BUYERS UPBEAT AT MALAYSIAN INTERNATIONAL FURNITURE FAIR 2024

More international buyers and orders sealed KUALA LUMPUR, Malaysia, April 9, 2024…
Iridium Signs Five-Year Contract with L3Harris to Protect FAA Critical Infrastructure

Iridium Signs Five-Year Contract with L3Harris to Protect FAA Critical Infrastructure

Latest deployment of Iridium STL will provide a resilient timing sync service…
DFI Elevates Electric Vehicle Charging Experience at Embedded World 2024

DFI Elevates Electric Vehicle Charging Experience at Embedded World 2024

DFI to showcase the latest embedded solution powered by Intel TAIPEI, April…
Altair Wins 2024 Google Cloud North America Partner of the Year Award for Diversity, Equity, and Inclusion

Altair Wins 2024 Google Cloud North America Partner of the Year Award for Diversity, Equity, and Inclusion

Award recognizes Google Cloud partner that best prioritized DEI initiatives to transform…
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting

GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting

SHANGHAI and SAN DIEGO, April 9, 2024 /PRNewswire/ — GenFleet Therapeutics, a…